Foghorn Therapeutics (FHTX)Deerfield Management Company, L.P. added to its stake +509K shares
Deerfield Management Company, L.P. added to its stake in Foghorn Therapeutics, per its Q3 2024 13F.
- 3.03M
- Shares reported · +509K vs prior quarter
- 0.47%
- Disclosed portfolio weight
- $28.2M
- Reported value
- Holdings as of
- Sep 30, 2024
- Filed
- Nov 14, 2024
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Foghorn Therapeutics
OQRO holds no insider, Congress, fund or contract record for Foghorn Therapeutics dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its FHTX page.
How this filing works
Other disclosures at Foghorn Therapeutics
Everything OQRO holds on this company is on its FHTX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data